Alfred Sidney Barritt IV, MD (SB): My name is Sid Barritt, and I am a transplant hepatologist. I am professor of medicine and director of hepatology at the University of North Carolina. HoChong Gilles ...

Oxymetazoline, 0.1% may hold potential as a promising treatment option for individuals with acquired blepharoptosis, according to results of a pooled analysis published in JAMA Ophthalmology.

Other tricyclic antidepressants (TCAs), which were named after their characteristic biochemical structure, followed with different dose potencies and side-effect profiles but comparable efficacy. The ...

Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...

Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically N0 Neck in Head and Neck Squamous Cell Carcinoma This editorial accompanies an article by Huang et al 4 that reports ...

A new review shows secukinumab continued to have a strong safety profile after 6 years on the market. Secukinumab (Cosentyx) has become a widely used therapy for patients with psoriatic diseases. A ...

Podophyllotoxin (PPT), an aryltetralin-type lignan isolated from Podophyllum species, exhibits a wide range of biologic and pharmacologic activities, and mainly serves as an antiviral agent or ...

While pharmacologic interventions are common for insomnia disorder, many are poorly tolerated and can lead to significant adverse events, according to a systematic review and network meta-analysis.

Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. Resistance to alkylators may potentially be overcome by drugs that inhibits DNA repair, thus ...

Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...